MapLight Therapeutics, Inc. - Common Stock (MPLT)
MapLight Therapeutics, Inc. - Common Stock (MPLT) last closed at $13.14 (as of 2026-09-03). On Shishin's four-engine momentum model it scored 34/100, flagged by the Suzaku engine on its most recent scan appearance (2026-07-20). It has surfaced in 3 daily scans since 2026-07-13. The figures below are research data, the Shishin Score and the momentum, trend, and volatility indicators the engines observe, not investment advice.
Price updates daily; the engine read reflects MPLT's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.
MPLT did not make Shishin's board on 2026-09-03: below the liquidity floor (under about $20M traded/day). This is a mechanical screen result, not a view on the company.
MPLT's Shishin Score has faded 2 points (from 36 to 34/100) across its recent scans, momentum-of-score is cooling.
What is MPLT's Shishin momentum score?
As of 2026-07-20, MPLT scores 34/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.
Is MPLT showing a momentum setup?
MPLT's current setup state is "OTHER." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.
Which Shishin engine flags MPLT?
Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.
How often has MPLT appeared in Shishin scans?
MPLT has appeared in 3 daily scans since 2026-07-13. Recurring appearances indicate a persistent setup; one-off appearances are more transient.
How is the Shishin Score calculated?
The Shishin Score (0 to 100) is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.
Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.